NCT06218680

Brief Summary

The goal of this clinical trial is to compare Efficacy of low dose propofol(0.5 mg/kg) vs placebo given at the end of sevoflurane anesthesia for prevention of emergence agitation in pediatric patient undergoing MRI scan. The main question it aims to answer is "Can low dose propofol reduce the incidence of emergence agitation after general anesthesia?" Participants will be given propofol 0.5 mg/kg or saline according to the allocated group at the completion of MRI scan

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

January 20, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

January 23, 2024

Status Verified

January 1, 2024

Enrollment Period

1.3 years

First QC Date

January 12, 2024

Last Update Submit

January 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence of emergence agitation

    at 5,10,15,20,25,30 minutes after extubation

Secondary Outcomes (4)

  • Incidence of complication

    2 hours after extubation

  • Use of rescue medication

    2 hours after extubation

  • Emergence time

    2 hours after extubation

  • Length of stay in post anesthetic care unit

    2 hours after extubation

Study Arms (2)

group P

EXPERIMENTAL

Receive 0.5 mg/kg of propofol intravenously at end of sevoflurane anesthesia

Drug: Propofol

group S

PLACEBO COMPARATOR

Receive saline intravenously at end of sevoflurane anesthesia

Drug: Normal saline

Interventions

recieve propofol 0.5 mg/kg intravenously at end of sevoflurane anesthesia

group P

recieve propofol 0.5 mg/kg intravenously at end of sevoflurane anesthesia

group S

Eligibility Criteria

Age1 Year - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 2-8 years
  • ASA class I or II ,who schedule for MRI scan under sevoflurane anesthesia

You may not qualify if:

  • Developmental delay
  • Psychological and neurological disorders
  • Abnormal airway
  • Reactive airway disease
  • Allergy to propofol, egg product
  • Family history of malignant hyperthermia
  • Need iv sedative medication before induction
  • Obesity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Khon kaen University

Khon Kaen, Muang, 40002, Thailand

Location

Related Publications (7)

  • Kulka PJ, Bressem M, Tryba M. Clonidine prevents sevoflurane-induced agitation in children. Anesth Analg. 2001 Aug;93(2):335-8, 2nd contents page.

    PMID: 11473855BACKGROUND
  • Welborn LG, Hannallah RS, Norden JM, Ruttimann UE, Callan CM. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg. 1996 Nov;83(5):917-20. doi: 10.1097/00000539-199611000-00005.

    PMID: 8895263BACKGROUND
  • Aouad MT, Yazbeck-Karam VG, Nasr VG, El-Khatib MF, Kanazi GE, Bleik JH. A single dose of propofol at the end of surgery for the prevention of emergence agitation in children undergoing strabismus surgery during sevoflurane anesthesia. Anesthesiology. 2007 Nov;107(5):733-8. doi: 10.1097/01.anes.0000287009.46896.a7.

    PMID: 18073548BACKGROUND
  • Cravero JP, Beach M, Thyr B, Whalen K. The effect of small dose fentanyl on the emergence characteristics of pediatric patients after sevoflurane anesthesia without surgery. Anesth Analg. 2003 Aug;97(2):364-367. doi: 10.1213/01.ANE.0000070227.78670.43.

    PMID: 12873918BACKGROUND
  • Costi D, Ellwood J, Wallace A, Ahmed S, Waring L, Cyna A. Transition to propofol after sevoflurane anesthesia to prevent emergence agitation: a randomized controlled trial. Paediatr Anaesth. 2015 May;25(5):517-23. doi: 10.1111/pan.12617. Epub 2015 Jan 13.

    PMID: 25586124BACKGROUND
  • Ramlan AAW, Pardede DKB, Marsaban AHMS, Hidayat J, Peddyandhari FS. Efficacy of 0.5 mg/kg of propofol at the end of anesthesia to reduce the incidence of emergence agitation in children undergoing general anesthesia with sevoflurane. J Anaesthesiol Clin Pharmacol. 2020 Apr-Jun;36(2):177-181. doi: 10.4103/joacp.JOACP_257_19. Epub 2020 Jun 15.

    PMID: 33013031BACKGROUND
  • Abu-Shahwan I. Effect of propofol on emergence behavior in children after sevoflurane general anesthesia. Paediatr Anaesth. 2008 Jan;18(1):55-9. doi: 10.1111/j.1460-9592.2007.02376.x.

    PMID: 18095967BACKGROUND

MeSH Terms

Conditions

Emergence Delirium

Interventions

PropofolSaline Solution

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Santhita Pimonbut, M.D.

    department of anesthesiology, faculty of medicine, Khonkaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Santhita Pimonbut, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: RCT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Santhita Pimonbut

Study Record Dates

First Submitted

January 12, 2024

First Posted

January 23, 2024

Study Start

January 20, 2024

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

January 23, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

all collected individual participant data

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
6 month after publication
Access Criteria
Researcher who required more information for further study

Locations